About 52 Trademarks found that are owned by Oxford BIomedica Plc

Chemical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids, viral vectors or non viral vectors for gene therapy; pharmaceutical preparations containing nucleic acids, viral vectors or non viral vectors for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, neurodegenerative disorders, diseases of the eye which result in vision impairment or loss, diseases of the ear which result in hearing impairment or loss, and bodily conditions associated with impaired immune systems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, neurodegenerative disorders, diseases of the eye which result in vision impairment or loss, diseases of the ear which result in hearing impairment or loss, and bodily conditions associated with impaired immune systems

Instruments and apparatus for the administration of gene therapy products, namely, syringes, injectors, scalpels, catheters, indwelling catheters, pumps, tubes for the administration of gene therapy products; surgical instruments for the administration of gene therapy products

Color is not claimed as a feature of the mark.

In the statement, Page 2, Column 1, line 12,"12-9-2009" should be deleted, and 12-3-2009 should be inserted.

In the statement, page 2, line 6, 4-12-2009, is deleted and 12-4-2009, should be inserted.

Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations

Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, namely, medical syringes and injectors for medical purposes

Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical treatment purposes; pharmaceuticals for medical purposes for the delivery of genes to cells; viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes; pre-filled vials for medical purposes and for pharmaceutical and biochemical preparations, for use in gene therapy and for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders

Medical services

Gene therapy products for medical use, namely, clinical medical reagents, liposome reagents, nucleic acids, and vaccines for use in gene therapy, gene-based medicines, chemotherapeutics, and pharmaceutical preparations for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, neuro-degenerative disorders, cardiac disorders, cystic fibrosis, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes for use in gene delivery technologies; retroviral vector manufacturing preparations and retroviral vector preparations for medical use for gene delivery technologies; chemical products for medical use for genetic engineering and in gene therapy; none of the foregoing goods including or for use in connection with immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens

Chemicals for use in industry and science, namely, enzymes for scientific and research purposes; chemical products for in-vitro use in laboratories and for analysis, namely, enzymes and chemicals for use in gene delivery technology for laboratory and research use; micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, namely, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in-vivo use

Gene therapy and prophylaxis products, namely, gene delivery pharmaceuticals; pharmaceuticals for the delivery of genes to muscle cells, all for medical purposes; vaccines, enzymes, and enzyme preparations for the treatment of cancer; hypoxia response pharmaceutical substances and preparations, viral and retroviral vectors, viral and retroviral vector manufacturing preparations for the treatment of cancer; pharmaceutical and biochemical preparations for the treatment of cancer

Gene therapy products, namely, gene-based medicines and injectable pharmaceuticals for the treatment of neuro-degenerative disorders;enzymes and enzyme preparations for medical purposes, namely, for the treatment of neuro-degenerative disorders; retroviral vector preparations and manufacture of retroviral vector preparations, all for use in gene-based medicines and injectable pharmaceuticals for the treatment of neuro-degenerative disorders; chemical products for in vitro diagnosis for medical use, excluding products for veterinary purposes

Instruments and apparatus for the administration of gene therapy, namely, injection devices, syringes, scalpels, catheters and tubes for medical services; surgical and medical apparatus and instruments, namely, injection devices, syringes, scalpels, catheters, tubes for medical services, excluding products for veterinary purposes

Material treatment, namely, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology

Material treatment, namely, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology

In the heading, delete class 42. Statement(s): Column 2, line 2, after "technologies" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 4, after "products" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 13 after "vascularisation" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" should be inserted.

In the statement, Page 2, Column 1, line 15, after "Vascularisation" and injuries of the nervous, system, all should be inserted.

CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS

INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS, NAMELY, SYRINGES, SCALPELS, CATHETERS AND TUBES FOR MEDICAL SERVICES